Boston University Clinical and Translational Science Institute

波士顿大学临床与转化科学研究所

基本信息

批准号：
10086522
负责人：
MEGAN H BAIR-MERRITT
金额：
$ 645.76万
依托单位：
BOSTON UNIVERSITY MEDICAL CAMPUS
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-08-13 至 2025-03-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10086522
关键词：
Academic Medical Centers Address Advocate Basic Science Boston Caring Clinical Research Clinical Sciences Clinical Trials Clinical and Translational Science Awards Collaborations Communities Cultural Diversity Development Diagnostic Disadvantaged Diverse Workforce Environment Ethnic Origin Funding Gender Goals Health Health Sciences Health system Healthcare Hospitals Immigrant Individual Informatics Infrastructure Institutes Insurance Language Learning Longevity Maintenance Medicaid Medical center Methods New England Outcome Participant Patients Performance Physicians Policy Maker Population Principal Investigator Process Provider Public Policy Race Recording of previous events Research Research Infrastructure Research Institute Resources Risk Science Scientist Socioeconomic Status Substance Use Disorder Training Translational Research Underinsured United States National Institutes of Health Universities Veterans Hospitals Vision Workforce Development catalyst design disorder control empowered ethnic diversity health care disparity health disparity improved inner city innovation low socioeconomic status member multidisciplinary named group novel novel strategies patient population programs racial diversity residence safety net tool

项目摘要

The Boston University Clinical and Translational Science Institute (BU CTSI) is an innovative CTSA clinical and translational research hub and catalyst for national CTSA network science. Boston University and partner, Boston Medical Center Health System (affiliate with Boston HealthNet, Boston Accountable Care Organization, VA Boston Health System, Edith Norse Rogers Veterans Hospital and the HealthCore/New England Research Institutes, Inc.) to comprise the members of the BU CTSI. We serve the largest URG and At Risk patient populations in New England. Our overarching theme is meant to emphasize our commitment to developing translational research infrastructure that is appropriate and innovative to meet the standards of the CTSA Network AND is uniquely designed to meet the needs and overcome the many barriers in partnering in research with patients at risk for poor health and outcomes. In order to address the health needs of these communities, the BU CTSI will support workforce development, collaboration across our stakeholders and integration of translational science across the lifespan of our Special Populations the through the development of a competent workforce, use of novel informatics, methods and processes that address disparities of health care. The BU CTSI Goals are: Aim 1. Discover, demonstrate, deploy and disseminate novel methods in training that will enhance our entire translational science workforce and create opportunities for advancement. Aim 2. Develop the most efficient, most representative clinical trials hub possible employing the integrated resources of all our partners. Aim 3. Effect meaningful multi-directional relationships among all our community stakeholders that strengthen collaborative translational research across the lifespan of our special populations and enable novel approaches to integrating research into health care. Aim 4. In collaboration with other CTSA hubs, discover, develop and disseminate innovative tools to improve research on treatments and diagnostics that address national health problems: The BU CTSI’s vision is to be the strongest possible advocate for, and participant in, translational research that serves the health needs of our diverse At Risk patient populations by working with our community to create unique resources that can be integrated with and distributed to the national CTSA network.

波士顿大学临床和转化科学研究所 (BU CTSI) 是一家创新型 CTSA 临床和转化研究所波士顿大学和合作伙伴的转化研究中心和国家 CTSA 网络科学的催化剂。波士顿医疗中心健康系统（隶属于波士顿健康网、波士顿责任医疗组织、 VA 波士顿卫生系统、Edith Norse Rogers 退伍军人医院和 HealthCore/新英格兰研究中心 Institutes, Inc.）由 BU CTSI 成员组成，我们为最大的 URG 和高危患者提供服务。我们的首要主题是强调我们对发展的承诺。适当且创新的转化研究基础设施，以满足 CTSA Network AND 的设计独特，旨在满足需求并克服许多障碍与面临健康状况和结果不佳风险的患者合作进行研究，以解决健康问题。为了满足这些社区的需求，BU CTSI 将支持劳动力发展和跨部门协作利益相关者以及转化科学在特殊人群整个生命周期中的整合培养一支有能力的劳动力队伍，使用新颖的信息学、方法和流程来解决 BU CTSI 的目标是：目标 1. 在培训中发现、演示、部署和传播新方法，这将增强我们的整体能力转化科学劳动力并创造晋升机会。目标 2. 利用综合技术开发最高效、最具代表性的临床试验中心我们所有合作伙伴的资源。目标 3. 在我们所有社区利益相关者之间建立有意义的多维关系，以加强跨特殊人群生命周期的合作转化研究并实现新方法将研究融入医疗保健。目标 4. 与其他 CTSA 中心合作，发现、开发和传播创新工具以改进解决国民健康问题的治疗和诊断研究： BU CTSI 的愿景是成为转化研究最强有力的倡导者和参与者，通过与我们的社区合作，满足我们多样化的高危患者群体的健康需求可以与国家 CTSA 网络集成并分发到的独特资源。